These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 23427436

  • 21. [Effect of 4B3 monoclonal antibody on the experimental Cryptococcus neoformans infection].
    Illnait-Zaragozí MT, Gato Armas R, Martínez Machín GF, Otero González A, Sarracent Pérez J, Rodríguez Sánchez H, Fernández Andreu CM, Valdés Hernández Idel C.
    Rev Cubana Med Trop; 2011; 63(2):123-9. PubMed ID: 23437519
    [Abstract] [Full Text] [Related]

  • 22. Aspects of antigen mimicry revealed by immunization with a peptide mimetic of Cryptococcus neoformans polysaccharide.
    Valadon P, Nussbaum G, Oh J, Scharff MD.
    J Immunol; 1998 Aug 15; 161(4):1829-36. PubMed ID: 9712050
    [Abstract] [Full Text] [Related]

  • 23. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans.
    Beenhouwer DO, Shapiro S, Feldmesser M, Casadevall A, Scharff MD.
    Infect Immun; 2001 Oct 15; 69(10):6445-55. PubMed ID: 11553589
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies.
    Todaro-Luck F, Reiss E, Cherniak R, Kaufman L.
    Infect Immun; 1989 Dec 15; 57(12):3882-7. PubMed ID: 2680986
    [Abstract] [Full Text] [Related]

  • 27. Effect of antibody to capsular polysaccharide on eosinophilic pneumonia in murine infection with Cryptococcus neoformans.
    Feldmesser M, Kress Y, Casadevall A.
    J Infect Dis; 1998 Jun 15; 177(6):1639-46. PubMed ID: 9607844
    [Abstract] [Full Text] [Related]

  • 28. Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity.
    Netski D, Kozel TR.
    Infect Immun; 2002 Jun 15; 70(6):2812-9. PubMed ID: 12010967
    [Abstract] [Full Text] [Related]

  • 29. Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans.
    Brandt S, Thorkildson P, Kozel TR.
    Clin Diagn Lab Immunol; 2003 Sep 15; 10(5):903-9. PubMed ID: 12965925
    [Abstract] [Full Text] [Related]

  • 30. Effect of immune mechanisms on the pharmacokinetics and organ distribution of cryptococcal polysaccharide.
    Lendvai N, Casadevall A, Liang Z, Goldman DL, Mukherjee J, Zuckier L.
    J Infect Dis; 1998 Jun 15; 177(6):1647-59. PubMed ID: 9607845
    [Abstract] [Full Text] [Related]

  • 31. Simultaneous expression of kappa and lambda light chains in a murine IgG3 anti-Cryptococcus neoformans hybridoma cell line.
    Spira G, Yuan R, Paizi M, Weisendal M, Casadevall A.
    Hybridoma; 1994 Dec 15; 13(6):531-5. PubMed ID: 7737677
    [Abstract] [Full Text] [Related]

  • 32. Monoclonal antibody mediated capsular reactions (Quellung) in Cryptococcus neoformans.
    Mukherjee J, Cleare W, Casadevall A.
    J Immunol Methods; 1995 Jul 17; 184(1):139-43. PubMed ID: 7622865
    [Abstract] [Full Text] [Related]

  • 33. Production of monoclonal antibodies for detecting marine fungal polysaccharide isolated from the Phoma herbarum YS4108.
    Zhao H, Feng W, Zhang H, Zhou X, Xu S, Gao X.
    Immunol Invest; 2008 Jul 17; 37(8):770-81. PubMed ID: 18991095
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.
    Mukherjee J, Scharff MD, Casadevall A.
    Infect Immun; 1995 Sep 17; 63(9):3353-9. PubMed ID: 7642262
    [Abstract] [Full Text] [Related]

  • 38. Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals.
    Deshaw M, Pirofski LA.
    Clin Exp Immunol; 1995 Mar 17; 99(3):425-32. PubMed ID: 7882565
    [Abstract] [Full Text] [Related]

  • 39. [The isolation of monoclonal antibodies to Cryptococcus neoformans antigens].
    Khrapova NP, Lesovoĭ VS, Prokhvatilova EV, Stupenko LN, Zharkova SF.
    Zh Mikrobiol Epidemiol Immunobiol; 1999 Mar 17; (6):70-4. PubMed ID: 10876856
    [Abstract] [Full Text] [Related]

  • 40. Monoclonal antibody-mediated toxicity in Cryptococcus neoformans infection: mechanism and relationship to antibody isotype.
    Lendvai N, Casadevall A.
    J Infect Dis; 1999 Sep 17; 180(3):791-801. PubMed ID: 10438368
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.